CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- PRE 14A Proxy Proxy Statement (Preliminary)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,227 shares at $1.42 ($3,162)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,554 shares at $1.37 ($3,499)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 1,033 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,787 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,180 shares (to pay taxes)
- 8-K Event Executive or director change
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 3,248 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 1,163 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,353 shares (to pay taxes)
Page 11 of 24 · 464 filings